Multiple sclerosis risk in radiologically uncovered asymptomatic possible inflammatory-demyelinating disease

Multiple Sclerosis

Volumn 15, Issue 8, 2009, Pages 918-927

  Siva, A ^a   Saip, S ^a   Altintas, A ^a   Jacob, A ^b   Keegan, B M ^c   Kantarci, Orhun H ^c,d  

^a ISTANBUL UNIVERSITY   (Turkey)

^b WALTON CENTRE FOR NEUROLOGY AND NEUROSURGERY   (United Kingdom)

^c Mayo Clinic College of Medicine   (United States)

^d MAYO CLINIC   (United States)

Author keywords

Asymptomatic; Multiple sclerosis; Natural history; Radiologically isolated syndrome; RAPIDD

Indexed keywords

ADOLESCENT; ADULT; ARTICLE; CLINICAL ARTICLE; CLINICAL FEATURE; CONTROLLED STUDY; DEMYELINATING DISEASE; DISEASE COURSE; FEMALE; HEADACHE; HUMAN; INFLAMMATION; MALE; MULTIPLE SCLEROSIS; MYELITIS; NEUROIMAGING; NUCLEAR MAGNETIC RESONANCE IMAGING; PARESTHESIA; RADIOLOGICALLY UNCOVERED ASYMPTOMATIC POSSIBLE INFLAMMATORY DEMYELINATING DISEASE; RISK ASSESSMENT; SURVIVAL; SYNCOPE; TERTIARY HEALTH CARE;

ADULT; AGED; DEMYELINATING DISEASES; DISEASE PROGRESSION; FEMALE; FOLLOW-UP STUDIES; HUMANS; INCIDENTAL FINDINGS; INFLAMMATION; MAGNETIC RESONANCE IMAGING; MALE; MIDDLE AGED; MINNESOTA; MULTIPLE SCLEROSIS; PROSPECTIVE STUDIES; RISK ASSESSMENT; RISK FACTORS; SYNDROME; TIME FACTORS; TURKEY;

EID: 69549120395     PISSN: 13524585     EISSN: None     Source Type: Journal    
DOI: 10.1177/1352458509106214     Document Type: Article

References (34)

1. Polman, CH, Reingold, SC, Edan, G, et al. Diagnostic criteria for multiple sclerosis: 2005 revisions to the "McDonald Criteria" Ann Neurol 2005; 58: 840-846 [see comment].
2. Barkhof, F, Filippi, M, Miller, DH, et al. Comparison of MRI criteria at first presentation to predict conversion to clinically definite multiple sclerosis. Brain 1997; 120: 2059-2069.
3. Tintore, M, Rovira, A, Martinez, MJ, et al. Isolated demyelinating syndromes: Comparison of different MR imaging criteria to predict conversion to clinically definite multiple sclerosis. AJNR Am J Neuroradiol 2000; 21: 702-706.
4. Tintore, M, Rovira, A, Rio, J, et al. Baseline MRI predicts future attacks and disability in clinically isolated syndromes. Neurology 2006; 67: 968-972.
5. Tintore, M, Rovira, A, Rio, J, et al. Do oligoclonal bands add information to MRI in first attacks of multiple sclerosis. Neurology 2008; 70: 1079-1083.
6. Pulicken, M, Gordon-Lipkin, E, Balcer, LJ, Frohman, E, Cutter, G, Calabresi, PA. Optical coherence tomography and disease subtype in multiple sclerosis. Neurology 2007; 69: 2085-2092.
7. Sisto, D, Trojano, M, Vetrugno, M, Trabucco, T, Iliceto, G, Sborgia, C. Subclinical visual involvement in multiple sclerosis: A study by MRI, VEPs, frequency-doubling perimetry, standard perimetry, and contrast sensitivity. Invest Ophthalmol Vis Sci 2005; 46: 1264-1268.
8. Engell, T. A clinical patho-anatomical study of clinically silent multiple sclerosis. Acta Neurologica Scandinavica 1989; 79: 428-430 [see comment].
9. Mews, I, Bergmann, M, Bunkowski, S, Gullotta, F, Bruck, W. Oligodendrocyte and axon pathology in clinically silent multiple sclerosis lesions. Mult Scler 1998; 4: 55-62.
10. Constantinescu, CS, Grossman, RI, Finelli, PF, Kamoun, M, Zmijewski, C, Cohen, JA. Clinical and subclinical neurological involvement in children of conjugal multiple sclerosis patients. Mult Scler 1995; 1: 170-172.
11. De Stefano, N, Cocco, E, Lai, M, et al. Imaging brain damage in first-degree relatives of sporadic and familial multiple sclerosis. Annals of Neurology 2006; 59: 634-639 [see comment].
12. Duquette, P, Charest, L. Cerebrospinal fluid findings in healthy siblings of multiple sclerosis patients. Neurology 1986; 36: 727-729.
13. Fulton, JC, Grossman, RI, Mannon, LJ, Udupa, J, Kolson, DL. Familial multiple sclerosis: Volumetric assessment in clinically symptomatic and asymptomatic individuals. Mult Scler 1999; 5: 74-77.
14. Haghighi, S, Andersen, O, Oden, A, Rosengren, L. Cerebrospinal fluid markers in MS patients and their healthy siblings. Acta Neurol Scand 2004; 109: 97-99.
15. Haghighi, S, Andersen, O, Rosengren, L, Bergstrom, T, Wahlstrom, J, Nilsson, S. Incidence of CSF abnormalities in siblings of multiple sclerosis patients and unrelated controls. J Neurol 2000; 247: 616-622.
16. Lynch, SG, Rose, JW, Smoker, W, Petajan, JH. MRI in familial multiple sclerosis. Neurology 1990; 40: 900-903 [see comment].
17. Sadovnick, AD, Armstrong, H, Rice, GP, et al. A population-based study of multiple sclerosis in twins: Update. Ann Neurol 1993; 33: 281-285.
18. Tienari, PJ, Salonen, O, Wikstrom, J, Valanne, L, Palo, J. Familial multiple sclerosis: MRI findings in clinically affected and unaffected siblings. J Neurol Neurosurg Psychiatry 1992; 55: 883-886.
19. Uitdehaag,BM, Polman, CH, Valk, J, Koetsier, JC, Lucas, CJ. Magnetic resonance imaging studies in multiple sclerosis twins. J Neurol Neurosurg Psychiatry 1989; 52: 1417-1419.
20. Lyoo, IK, Seol, HY, Byun, HS, Renshaw, PF. Unsuspected multiple sclerosis in patients with psychiatric disorders: A magnetic resonance imaging study. The Journal of neuropsychiatry and clinical neurosciences 1996; 8: 54-59.
21. Poser, CM, Paty, DW, Scheinberg, L, et al. New diagnostic criteria for multiple sclerosis: Guidelines for research protocols. Ann Neurol 1983; 13: 227-231.
22. Poser, CM. The multiple sclerosis trait and the development of multiple sclerosis: Genetic vulnerability and environmental effect. Clin Neurol Neurosurgery 2006; 108: 227-233.
23. Siva, A, O'Connor, P, Saip, S, Kocer, N, Islak, C, Kantarci, O. Evolution of asymptomatic MS into clinically isolated syndromes. Neurology 2007; 68: A162.
24. Lebrun, C, Bensa, C, Debouverie, M, et al. Unexpected multiple sclerosis: Follow-up of 30 patients with magnetic resonance imaging and clinical conversion profile. J Neurol Neurosurg Psychiatry 2008; 79: 195-198.
25. Okuda, DT, Mowry, EM, Beheshtian, A, et al. Incidental MRI anomalies suggestive of multiple sclerosis. The radiologically isolated syndrome. Neurology 2009; 72: 800-805.
26. Comi, G, Filippi, M, Barkhof, F, et al. Effect of early interferon treatment on conversion to definite multiple sclerosis: A randomised study. Lancet 2001; 357: 1576-1582.
27. Jacobs, LD, Beck, RW, Simon, JH, et al. Intramuscular interferon beta-1a therapy initiated during a first demyelinating event in multiple sclerosis. CHAMPS Study Group. N Engl J Med 2000; 343: 898-904 [see comment].
28. Kappos, L, Polman, CH, Freedman, MS, et al. Treatment with interferon beta-1b delays conversion to clinically definite and McDonald MS in patients with clinically isolated syndromes. Neurology 2006; 67: 1242-1249.
29. O'Connor, P. The effects of intramuscular interferon beta-Ia in patients at high risk for development of multiple sclerosis: A post hoc analysis of data from CHAMPS. Clin Ther 2003; 25: 2865-2874.
30. Kantarci, O, Siva, A, Eraksoy, M, et al. Survival and predictors of disability in Turkish MS patients. Turkish Multiple Sclerosis Study Group (TUMSSG). Neurology 1998; 51: 765-772.
31. Fazekas, F, Offenbacher, H, Fuchs, S, et al. Criteria for an increased specificity of MRI interpretation in elderly subjects with suspected multiple sclerosis. Neurology 1988; 38: 1822-1825.
32. Comi, G. preCISe study. Neurology Presented at the 60th Annual Meeting of the American Academy of Neurology (AAN), Chicago IL, April 16, 2008.
33. Siger-Zajdel, M, Selmaj, K. Proton magnetic resonance spectroscopy of normal appearing white matter in asymptomatic relatives of multiple sclerosis patients. Eur J Neurol 2006; 13: 296-298.
34. Hakiki, B, Goretti, B, Portaccio, E, Zipoli, V, Amato, MP. 'Subclinical MS': Follow-up of four cases. Eur J Neurol 2008; 15: 858-861.